Sander Duncan

Sander Duncan is a healthcare executive with over a decade of experience in the industry. Sander is currently the Director at 64x Bio, a venture capital firm that invests in software-driven companies enabling next-generation care delivery and drug discovery.

Prior to their current role, Duncan served as a General Partner at Lifeforce Capital, where they helped invest in early-stage healthcare companies. Sander also served on the Board of Directors for UCSF Health Hub, a non-profit organization that supports the growth of healthcare startups.

In their previous role as VP of Business Development at Pager, Duncan was responsible for developing the company's payer and provider strategy, as well as running Business and Corporate Development. Sander also advised Pager while they were at Northwell Ventures.

Prior to their venture capital career, Duncan worked as an Associate at HealthpointCapital and Rigby Lab. Sander also spent time at Cleveland Clinic Ventures and Northwell Ventures.

Sander Duncan has a B.A. from Dartmouth College in Molecular Biology, which they obtained in 2009. Sander was involved in various extracurricular activities while at Dartmouth, including founding and being president of the Dartmouth Entrepreneurial Society, co-chairing Big Brother Big Sister, and playing rugby for Theta Delta Chi. Prior to Dartmouth, Duncan attended The Thacher School from 2001 to 2005.